MX380173B - Estructura de biomaterial para regenerar la mucosa oral - Google Patents

Estructura de biomaterial para regenerar la mucosa oral

Info

Publication number
MX380173B
MX380173B MX2017005373A MX2017005373A MX380173B MX 380173 B MX380173 B MX 380173B MX 2017005373 A MX2017005373 A MX 2017005373A MX 2017005373 A MX2017005373 A MX 2017005373A MX 380173 B MX380173 B MX 380173B
Authority
MX
Mexico
Prior art keywords
hydrogel
oral mucosa
regenerate
biomaterial scaffold
subjecting
Prior art date
Application number
MX2017005373A
Other languages
English (en)
Spanish (es)
Other versions
MX2017005373A (es
Inventor
Orts Amparo Baiget
Feo Begoña Castro
Original Assignee
Histocell Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Histocell Sl filed Critical Histocell Sl
Publication of MX2017005373A publication Critical patent/MX2017005373A/es
Publication of MX380173B publication Critical patent/MX380173B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/225—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3616—Blood, e.g. platelet-rich plasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
MX2017005373A 2014-10-24 2015-10-23 Estructura de biomaterial para regenerar la mucosa oral MX380173B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14382417.5A EP3011981A1 (en) 2014-10-24 2014-10-24 A biomaterial scaffold for regenerating the oral mucosa
PCT/EP2015/074610 WO2016062862A1 (en) 2014-10-24 2015-10-23 A biomaterial scaffold for regenerating the oral mucosa

Publications (2)

Publication Number Publication Date
MX2017005373A MX2017005373A (es) 2017-07-28
MX380173B true MX380173B (es) 2025-03-12

Family

ID=51844651

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017005373A MX380173B (es) 2014-10-24 2015-10-23 Estructura de biomaterial para regenerar la mucosa oral

Country Status (11)

Country Link
US (1) US11241516B2 (enExample)
EP (2) EP3011981A1 (enExample)
JP (1) JP6633628B2 (enExample)
KR (1) KR102489773B1 (enExample)
CN (1) CN107073170B (enExample)
AU (1) AU2015334897B2 (enExample)
BR (1) BR112017008117B1 (enExample)
CA (1) CA2964501C (enExample)
ES (1) ES2774792T3 (enExample)
MX (1) MX380173B (enExample)
WO (1) WO2016062862A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230126745A (ko) 2016-12-07 2023-08-30 메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 망막 색소 상피 이식을 위해 피브린 지지체를 사용하는 방법 및 물질
US11419892B2 (en) 2018-02-01 2022-08-23 North Carolina State University Antimicrobial platelet-like particles
US12234478B2 (en) * 2018-05-07 2025-02-25 Reelabs Pvt. Ltd. Method of autologous primary hair follicles preparation in 3D culture
WO2020033713A1 (en) * 2018-08-08 2020-02-13 Northeastern University Oxygen-generating cryogels
CN110760076B (zh) * 2019-11-06 2022-04-08 大连理工大学 一种基于胶体颗粒-iPRF双网络结构的可注射、高强度复合水凝胶及其制备方法和应用
CN110743038B (zh) * 2019-11-06 2021-09-10 大连理工大学 一种双网络结构复合水凝胶及其制备方法和应用
US20230015266A1 (en) * 2019-11-29 2023-01-19 North Carolina State University Neonatal fibrin scaffolds for promoting wound healing
CN110982125B (zh) * 2019-12-19 2022-01-21 武汉纺织大学 一种形状自恢复多孔复合凝胶及其制备方法与应用
CN113318275B (zh) * 2021-08-03 2021-11-02 首都医科大学附属北京口腔医院 用于牙髓牙本质再生的可降解水凝胶
CN113862332A (zh) * 2021-09-17 2021-12-31 浙江大学 琼脂糖在制备生物大分子冻干保护剂中的应用
CN114146223A (zh) * 2021-12-10 2022-03-08 三亚悦美科技有限公司 一种重组胶原蛋白复合注射剂及其制备方法
EP4241798A1 (en) * 2022-03-11 2023-09-13 Universidad de Granada Hydrogel suitable to produce artificial tissues
IL305612B2 (en) * 2023-08-31 2025-02-01 Redefine Meat Ltd Edible scaffolds, their preparation and use
WO2025173759A1 (ja) * 2024-02-16 2025-08-21 一般社団法人日本血液製剤機構 止血、組織接着・閉鎖、細胞の足場材料等のための生体材料としてのフィブリノゲンのゲル

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438198A (en) * 1981-09-30 1984-03-20 Trimedyne, Inc. Biochemically active matrix for use in a bio-artificial organ
WO1993010806A1 (en) 1991-11-25 1993-06-10 Institute Of Molecular Biology, Inc. Medicament for promoting growth of mammalian nerve
WO2000006724A1 (en) 1998-07-31 2000-02-10 Kirin Beer Kabushiki Kaisha Remedies for neuropathy containing as the active ingredient galectin-1 or its derivatives
IL144446A0 (en) * 2001-07-19 2002-05-23 Prochon Biotech Ltd Plasma protein matrices and methods for their preparation
US8080418B2 (en) * 2007-03-09 2011-12-20 Corning Incorporated Method of making a three dimensional cell culture matrix
DK2471902T3 (en) 2009-08-25 2018-08-06 Servicio Andaluz De Salud Preparation of artificial tissues by tissue engineering with agarose-fibrin biomaterials
KR20110023399A (ko) * 2009-08-31 2011-03-08 한국과학기술연구원 지혈효과 및 기계적 물성이 우수한 지능형 피브린 생체접착제
WO2011151832A1 (en) 2010-06-03 2011-12-08 Ramot At Tel-Aviv University Ltd. Malleable hydrogel hybrids made of self-assembled peptides and biocompatible polymers and uses thereof
EP2594295A1 (en) * 2011-11-16 2013-05-22 Servicio Andaluz De Salud Nerve implants based on a compacted biomaterial containing cells
CN102688525B (zh) * 2012-05-07 2013-11-27 东南大学 一种生物大分子水凝胶及其制备方法
CN103908693B (zh) * 2014-04-15 2015-10-28 山东颐诺生物科技有限公司 一种仿生型海藻酸基复合抗菌敷料及其制备方法

Also Published As

Publication number Publication date
AU2015334897B2 (en) 2019-08-01
EP3011981A1 (en) 2016-04-27
ES2774792T3 (es) 2020-07-22
BR112017008117B1 (pt) 2020-12-08
BR112017008117A2 (pt) 2018-02-20
CA2964501C (en) 2023-05-16
CN107073170B (zh) 2021-06-29
US11241516B2 (en) 2022-02-08
CN107073170A (zh) 2017-08-18
US20170340771A1 (en) 2017-11-30
AU2015334897A1 (en) 2017-05-18
EP3209341B1 (en) 2020-01-01
JP2017531533A (ja) 2017-10-26
CA2964501A1 (en) 2016-04-28
KR20170073673A (ko) 2017-06-28
EP3209341A1 (en) 2017-08-30
KR102489773B1 (ko) 2023-01-17
JP6633628B2 (ja) 2020-01-22
WO2016062862A1 (en) 2016-04-28
MX2017005373A (es) 2017-07-28

Similar Documents

Publication Publication Date Title
MX380173B (es) Estructura de biomaterial para regenerar la mucosa oral
CL2025001440A1 (es) Medios y método para preparar vectores virales y usos de los mismos
EP4219724A3 (en) Compositions and methods for treating non-age-associated hearing impairment in a human subject
CY1122275T1 (el) Μεσεγχυματικα στρωματικα κυτταρα και χρησεις που σχετιζονται με αυτα
CO2017011535A2 (es) Composiciones de ácido obeticólico y métodos de uso
NZ731789A (en) Isoindoline derivative, intermediate, preparation method, pharmaceutical composition and use thereof
EA201990293A1 (ru) Мультиспецифичные антитела против cd40 и cd137
EP3240551A4 (en) Methods of treating hematological disorders, solid tumors, or infectious diseases using natural killer cells
PE20181531A1 (es) Vacuna del virus herpes simple
HK1252568A1 (zh) 一种治疗方法
MX2018002344A (es) Metodo para tratar el cancer.
HK1251566A1 (zh) 作为hdac1/2抑制剂的呱啶衍生物
MX377300B (es) Terapia con células madre en patologías endometriales.
EA201492184A1 (ru) Способы лечения метаболического синдрома путем модулирования белка теплового шока (hsp) 90-бета
EA201791508A1 (ru) Способы трансдифференцировки и способы их использования
EA201890442A1 (ru) Получение фоторецепторов для лечения заболеваний сетчатки
MY182406A (en) Plant-adventitious-embryo induction method, plant restoration method, and plant reproduction method
FI20155951A7 (fi) Menetelmä selluloosan tuottamiseksi parenkyymisoluista
MX2017000142A (es) Celulas estromales mesenquimatosas para tratar el sindrome de respuesta inflamatoria sistemica.
PH12016501812A1 (en) Modified sulfamidase and production thereof
EP4249056A3 (en) Method for treating heart failure
MX2019008038A (es) Composiciones y metodos para tratar la enfermedad de farber.
BR112017025872A2 (pt) proteínas de ligação multiespecíficas
BR112017011513A2 (pt) tratamento de condições oculares usando células progenitoras
MX2023009895A (es) Compuestos y composiciones para tratar la fibrosis.